Singularity analysis of the AKT signaling pathway reveals connections between cancer and metabolic diseases

Physical Biology

Volumn 7, Issue 4, 2010, Pages

  Wang, Guanyu ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; METABOLIC DISORDER; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; METABOLIC DISEASES; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION;

EID: 79551478205     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/7/4/046015     Document Type: Article

References (60)

1. Giovannucci E 2007 Metabolic syndrome, hyperinsulinemia, and colon cancer: a review Am. J. Clin. Nutr. 86 s836-42
2. Pischon T, Nöthlings U and Boeing H 2008 Obesity and cancer Proc. Nutr. Soc. 67 128-45
3. Hsu I R, Kim S P, Kabir M and Bergman R N 2007 Metabolic syndrome, hyperinsulinemia, and cancer Am. J. Clin. Nutr. 86 s867-71
4. Larsson S C, Mantzoros C S and Wolk A 2007 Diabetes mellitus and risk of breast cancer: a meta-analysis Int. J. Cancer 121 856-62 (Pubitemid 47106217)
5. Giovannucci E, Harlan D M, Archer M C, Bergenstal R M, Gapstur S M, Habel L A, Pollak M, Regensteiner J G and Yee D 2010 Diabetes and cancer: a consensus report CA Cancer J. Clin. 60 207-21
6. Simon D and Balkau B 2010 Diabetes mellitus, hyperglycaemia and cancer Diabetes Metab. 36 182-91
7. Hirsch H A, Iliopoulos D, Joshi A, Zhang Y, Jaeger S A, Bulyk M, Tsichlis P N, Liu X S and Struhl K 2010 A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases Cancer Cell 17 348-61
8. Liao Y and Hung M C 2010 Physiological regulation of Akt activity and stability Am. J. Transl. Res. 2 19-42
9. Vanhaesebroeck B and Waterfield M D 1999 Signaling by distinct classes of phosphoinositide 3-kinases Exp. Cell Res. 253 239-54
10. Rajala R V 2010 Phosphoinositide 3-kinase signaling in the vertebrate retina J. Lipid Res. 51 4-22
11. Guertin D A and Sabatini D M 2005 An expanding role for mTOR in cancer Trends Mol. Med. 11 353-61
12. Guertin D A and Sabatini D M 2007 Defining the role of mTOR in cancer Cancer Cell 12 9-22
13. Soulard A and Hall M N 2007 Snapshot: mTOR signaling Cell 129 434
14. Menon S and Manning B D 2009 Common corruption of the mTOR signaling network in human tumors Oncogene 27 S43-51
15. Hietakangas V and Cohen S M 2009 Regulation of tissue growth through nutrient sensing Annu. Rev. Genet. 43 389-410
16. Ao P, Galas D, Hood L and Zhu X 2008 Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution Med. Hypotheses 70 678-84
17. Arnold V I 1981 Singularity Theory (London Mathematical Society Lecture Notes Series vol 53) (Cambridge: Cambridge University Press)
18. Golubitsky M and Schaeffer D G 1985 Singularities and Groups in Bifurcation Theory (New York: Springer)
19. Song H, Smolen P, Av-Ron E, Baxter D A and Byrne J H 2006 Bifurcation and singularity analysis of a molecular network for the induction of long-term memory Biophys. J. 90 2309-25
20. Goldbeter A and Koshland D E 1981 An amplified sensitivity arising from covalent modification in biological systems Proc. Natl Acad. Sci. USA 78 6840-4
21. Berg O G, Paulsson J and Ehrenberg M 2000 Fluctuations and quality of control in biological cells: zero-order ultrasensitivity reinvestigated Biophys. J. 79 1228-36
22. Qian H 2003 Amplifying signal transduction specificity without multiple phosphorylation Biophys. J. 84 1410-1
23. Barik D, Paul M R, Baumann W T, Cao Y and Tyson J J 2008 Stochastic simulation of enzyme-catalyzed reactions with disparate timescales Biophys. J. 95 3563-74
24. Kidd P B and Wingreen N S 2010 Modeling the role of covalent enzyme modification in Escherichia coli nitrogen metabolism Phys. Biol. 7 016006
25. Manning B D 2004 Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis J. Cell Biol. 167 399-403
26. O'Reilly K E et al 2006 mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt Cancer Res. 6 1500-8
27. Pfeuty B and Kaneko K 2009 The combination of positive and negative feedback loops confers exquisite flexibility to biochemical switches Phys. Biol. 6 046013
28. Kim D, Kwon Y K and Cho K H 2007 Coupled positive and negative feedback circuits form an essential building block of cellular signaling pathways Bioessays 29 85-90
29. Harris S L and Levine A J 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899-908
30. Benayoun B A, Batista F, Auer J, Dipietromaria A, L'Hote D, De Baere E and Veitia R A 2009 Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations Hum. Mol. Genet. 18 632-44
31. Paz K, Liu Y F, Shorer H, Hemi R, LeRoith D, Quan M, Kanety H, Seger R and Zick Y 1999 Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function J. Biol. Chem. 274 28816-22
32. Gual P, Marchand-Brustel Y Le and Tanti J F 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 99-109
33. Araujo R P, Liotta L A and Petricoin E F 2007 Proteins, drug targets and the mechanisms they control: the simple truth about complex networks Nat. Rev. Drug Discov. 6 871-80
34. Harrington L S, Findlay G M and Lamb R F 2005 Restraining PI3K: mTOR signalling goes back to the membrane Trends Biochem. Sci. 30 35-42
35. Harrington L S et al 2004 The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins J. Cell Biol. 166 213-23
36. Ferrell J E and Xiong W 2001 Bistability in cell signaling: how to make continuous processes discontinuous, and reversible processes irreversible Chaos 11 227-36
37. Qian H and Bishop L M 2010 The chemical master equation approach to nonequilibrium steady state of open biochemical systems: linear single-molecule enzyme kinetics and nonlinear biochemical reaction networks Int. J. Mol. Sci. 11 3472-500
38. Wee K B and Aguda B D 2006 Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death Biophys. J. 91 857-65
39. CampbellI G, Russell S E, Choong D Y, Montgomery K G, Ciavarella M L, Hooi C S, Cristiano B E, Pearson R B and Phillips W A 2004 Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res. 64 7678-81
40. Wang J et al 2007 Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis Mol. Cancer Ther. 6 1143-50
41. Loi S et al 2010 PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer Proc. Natl Acad Sci. USA 107 10208-13
42. Bryant N J, Govers R and James D E 2002 Regulated transport of the glucose transporter GLUT4 Nat. Rev. Mol. Cell Biol. 3 267-77
43. Kovacic S, Soltys C L, Barr A J, Shiojima I, Walsh K and Dyck J R 2003 Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart J. Biol. Chem. 278 39422-7
44. Neshat M S, Mellinghoff I K, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons J J, Wu H and Sawyers C L 2001 Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc. Natl Acad. Sci. USA 98 10314-9
45. Qian H and Reluga T C 2005 Nonequilibrium thermodynamics and nonlinear kinetics in a cellular signaling switch Phys. Rev. Lett. 94 028101
46. Lazar D F and Saltiel A R 2006 Lipid phosphatases as drug discovery targets for type 2 diabetes Nat. Rev. Drug Discov. 5 333-42
47. Unger R H 1991 Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells Science 251 1200-5
48. Browning J D and Horton J D 2004 Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 114 147-52
49. Reddy J K and Rao M S 2006 Lipid metabolism and liver inflammation: II. Fatty liver disease and fatty acid oxidation Am. J. Physiol. Gastrointest. Liver Physiol. 290 852-8
50. Cryer P E 2003 Glucose homestasis and hypoglycemia Williams Textbook of Endocrinology ed P R Larsen (Philadelphia, PA: Saunders) pp 1585-618
51. Qian H and Cooper J A 2008 Temporal cooperativity and sensitivity amplification in biological signal transduction Biochemistry 47 2211-20
52. Bobkova E V, Weber M J, Xu Z, Zhang Y L, Jung J, Blume-Jensen P, Northrup A, Kunapuli P, Andersen J N and Kariv I 2010 Discovery of PDK1 kinase inhibitors with a novel mechanism of action by ultrahigh throughput screening J. Biol. Chem. 285 18838-46
53. Hidalgo M and Rowinsky E K 2000 The rapamycin-sensitive signal transduction pathway as a target for cancer therapy Oncogene 19 6680-6
54. Petricoin E F et al 2007 Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival Cancer Res. 67 3431-40
55. Wysocki P J 2009 mTOR in renal cell cancer: modulator of tumor biology and therapeutic target Expert Rev. Mol. Diagn. 9 231-41
56. Granville C A, Memmott R M, Gills J J and Dennis P A 2006 Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway Clin. Cancer Res. 12 679-89
57. Calvo K R, Liotta L A and Petricoin E F 2005 Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy Biosci. Rep. 25 107-25
58. Dancey J E and Chen H X 2006 Strategies for optimizing combinations of molecularly targeted anticancer agents Nat. Rev. Drug Discov. 5 649-59
59. Wang G and Krueger G R 2010 Computational analysis of mTOR signalling pathway: bifurcation, carcinogenesis, and drug discovery Anticancer Res. 30 2683-8
60. Boissonade J and De Kepper P 1980 Transitions from bistability to limit cycle oscillations. Theoretical analysis and experimental evidence in an open chemical system J. Phys. Chem. 84 501-6